SPOTLIGHT -
Buprenorphine and Its Therapeutic Potential in Psychiatric Disorders
Researchers discuss new research on buprenorphine, the “gold standard” treatment for opioid use disorder at the APA Annual Meeting.
Should I Stay or Should I Go: IMGs and the US Health Care System During COVID-19
Frontline residents and fellows complain of “being forced to work harder than I can handle,” “being pushed to my limits,” “no availability of PPEs,” etc.
Opioid Overdoses and Naloxone: What Everyone Needs to Know
More than 6 out of 10 deaths involve prescribed opioids. The authors address guidelines for who should (and who should not) receive a naloxone prescription.
